These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 32524991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.
    Gevaert P, Saenz R, Corren J, Han JK, Mullol J, Lee SE, Ow RA, Zhao R, Howard M, Wong K, Islam L, Ligueros-Saylan M, Omachi TA, Bachert C.
    J Allergy Clin Immunol; 2022 Mar; 149(3):957-965.e3. PubMed ID: 34530020
    [Abstract] [Full Text] [Related]

  • 3. Biologics for chronic rhinosinusitis.
    Chong LY, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, Hopkins C, Burton MJ.
    Cochrane Database Syst Rev; 2021 Mar 12; 3(3):CD013513. PubMed ID: 33710614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP.
    Lancet; 2019 Nov 02; 394(10209):1638-1650. PubMed ID: 31543428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
    Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ.
    Cochrane Database Syst Rev; 2016 Apr 26; 4(4):CD011996. PubMed ID: 27115217
    [Abstract] [Full Text] [Related]

  • 14. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
    Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, Hellings P, Jiao L, Wang L, Evans RR, Pirozzi G, Graham NM, Swanson B, Hamilton JD, Radin A, Gandhi NA, Stahl N, Yancopoulos GD, Sutherland ER.
    JAMA; 2016 Feb 02; 315(5):469-79. PubMed ID: 26836729
    [Abstract] [Full Text] [Related]

  • 15. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
    Wu Q, Zhang Y, Kong W, Wang X, Yuan L, Zheng R, Qiu H, Huang X, Yang Q.
    Int Arch Allergy Immunol; 2022 Feb 02; 183(3):279-288. PubMed ID: 34607329
    [Abstract] [Full Text] [Related]

  • 16. The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma.
    Atayik E, Aytekin G, Aydin İ, Omeroglu E.
    Iran J Allergy Asthma Immunol; 2024 May 27; 23(3):245-256. PubMed ID: 39422385
    [Abstract] [Full Text] [Related]

  • 17. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
    Miglani A, Soler ZM, Smith TL, Mace JC, Schlosser RJ.
    Int Forum Allergy Rhinol; 2023 Feb 27; 13(2):116-128. PubMed ID: 35980852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Peters AT, Han JK, Hellings P, Heffler E, Gevaert P, Bachert C, Xu Y, Chuang CC, Neupane B, Msihid J, Mannent LP, Guyot P, Kamat S.
    J Allergy Clin Immunol Pract; 2021 Jun 27; 9(6):2461-2471.e5. PubMed ID: 33548517
    [Abstract] [Full Text] [Related]

  • 20. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
    Sui HJ, Zhen Z, Wang QG, Cong TC, Huang JJ, Hu Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb 06; 57(2):273-280. PubMed ID: 36797588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.